Cargando…
FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition
An emerging characteristic of drug resistance in cancer is the induction of epithelial-mesenchymal transition (EMT). However, the mechanisms of EMT-mediated drug resistance remain poorly defined. Therefore, we conducted long-term treatments of human epidermal growth factor receptor-2 (Her2)-transfor...
Autores principales: | Brown, Wells S., Akhand, Saeed Salehin, Wendt, Michael K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347779/ https://www.ncbi.nlm.nih.gov/pubmed/27825137 http://dx.doi.org/10.18632/oncotarget.13117 |
Ejemplares similares
-
Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
por: Abdullah, Ammara, et al.
Publicado: (2020) -
FGFR-2 and Epithelial–Mesenchymal Transition in Endometrial Cancer
por: Adamczyk-Gruszka, Olga, et al.
Publicado: (2022) -
Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer
por: Abdullah, Ammara, et al.
Publicado: (2023) -
Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
por: Ranieri, Danilo, et al.
Publicado: (2015) -
FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer
por: Peláez-García, Alberto, et al.
Publicado: (2013)